إعلان
إعلان
ALNY
Alnylam Pharmaceuticals, Inc.
425.70
USDبرعاية
+19.30
+4.75%
٠٧ يناير, ١٢:٣٤ UTC -5
مفتوح
تقارير أرباح ALNY
النسبة الإيجابية المفاجئة
ALNY تفوق 21 من 39 آخر التقديرات.
54%
التقرير التالي
الاسبوع القادم
بيانات التقرير القادم
١٢ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.20B
/$1.24
التغير الضمني من Q3 25 (Revenue/ EPS)
-4.19%
/-41.23%
التغير الضمني من Q4 24 (Revenue/ EPS)
+101.75%
/-290.77%
Alnylam Pharmaceuticals, Inc. earnings per share and revenue
On ٣٠ أكتوبر ٢٠٢٥, ALNY reported earnings of 2.11 USD per share (EPS) for Q3 25, beating the estimate of 0.76 USD, resulting in a 177.16% surprise. Revenue reached 1.25 مليار, compared to an expected 997.35 مليون, with a 25.23% difference. The market reacted with a -6.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 28 المحللين forecast an EPS of 1.24 USD, with revenue projected to reach 1.20 مليار USD, implying an نقصان of -41.23% EPS, and نقصان of -4.19% in Revenue from the last quarter.
الأسئلة الشائعة
What were Alnylam Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Alnylam Pharmaceuticals, Inc. reported EPS of $2.11, beating estimates by 177.16%, and revenue of $1.25B, 25.23% above expectations.
How did the market react to Alnylam Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -6.65%, changed from $481.59 before the earnings release to $449.56 the day after.
When is Alnylam Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ١٢ يناير ٢٠٢٦.
What are the forecasts for Alnylam Pharmaceuticals, Inc.'s next earnings report?
Based on 28
المحللين, Alnylam Pharmaceuticals, Inc. is expected to report EPS of $1.24 and revenue of $1.20B for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان